1. Home
  2. QUIK vs STTK Comparison

QUIK vs STTK Comparison

Compare QUIK & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$7.43

Market Cap

107.3M

Sector

Technology

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.63

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
STTK
Founded
1988
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.3M
119.0M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
QUIK
STTK
Price
$7.43
$4.63
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$11.00
$4.00
AVG Volume (30 Days)
121.0K
535.5K
Earning Date
02-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,178,999.00
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$73.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$0.69
52 Week High
$10.56
$4.89

Technical Indicators

Market Signals
Indicator
QUIK
STTK
Relative Strength Index (RSI) 68.32 78.83
Support Level $5.86 $3.15
Resistance Level $6.63 $3.29
Average True Range (ATR) 0.39 0.29
MACD 0.14 0.11
Stochastic Oscillator 97.83 84.36

Price Performance

Historical Comparison
QUIK
STTK

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: